Full description
Dataset includes: Data for 110 patients with relapsed or refractory multiple myeloma, in a randomised controlled trial of Elotuzumab-Cyclophosphamide-Thalidomide-Dexamethasone (E-CTD) with Cyclophosphamide-Thalidomide-Dexamethasone (CTD) Demographic data, diagnostic data, treatment data, outcome dataNotes
HeSANDA 1.0.0Issued: 2023
Subjects
User Contributed Tags
Login to tag this record with meaningful keywords to make it easier to discover
Other Information
Australasian Leukaemia And Lymphoma Group (ALLG)
ROR :
https://ror.org/05t72y326
Australasian Leukaemia and Lymphoma Group (ALLG)
Identifiers
- DOI : 10.58109/ZM9J-7X33